Brief: Xortx Therapeutics Inc Says Independent Proxy Firm, ISS, Recommends Shareholders Vote For Share Consolidation Resolution
12/10/2023 13:43
Oct 12 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX THERAPEUTICS INC - INDEPENDENT PROXY FIRM, ISS,
RECOMMENDS
SHAREHOLDERS VOTE FOR SHARE CONSOLIDATION RESOLUTION
Source text for Eikon: ID:nGNX6cYPZY
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering